| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2024―Jan―24 |
What makes SARS-CoV-2 unique? Focusing on the spike protein |
Jingbo Qian, Shichang Zhang, Fang Wang, Jinming Li, Jiexin Zhang |
| 2 |
[GO] |
2023―Jun―28 |
Relationship between CDX2 rs11568820 and EcoRV rs4516035 polymorphisms on the vitamin D receptor gene with susceptibility to different SARS-CoV-2 variants |
Abed K. K. Al-Mohammedawi, Enayat Anvari, Abolfazl Fateh |
| 3 |
[GO] |
2023―Mar―19 |
Exosomes in COVID-19 infection: Focus on role in diagnosis, pathogenesis, immunity, and clinical trials |
Alhanouf Aljuhani, Omniah Albalawi, Rahaf Albalawi, Reem Alsalama, Safyah Alatawi, Reem Altemani, et al. (+2) Mohamed S. Abdel-Maksoud, Nehal Elsherbiny |
| 4 |
[GO] |
2023―Feb―06 |
COVID-19: A trigger of autoimmune diseases |
Arghavan Zebardast, Ali Hasanzadeh, Seyedeh Arefeh Ebrahimian Shiadeh, Mehdi Tourani, Yousef Yahyapour |
| 5 |
[GO] |
2022―Dec―13 |
Study of frequency and inheritance model of ACE1 I/D and ACE2 rs2285666 polymorphisms in COVID-19 patients with varying severity of lung involvement and its effect on serum cytokines levels |
Shirin Beyranvand, Parivash Davoodian, Hesam Alizade, Hamed Gouklani, Azim Nejatizadeh, Ebrahim Eftekhar, Amin Reza Nikpoor |
| 6 |
[GO] |
2022―Oct―14 |
SARS-CoV-2 cellular tropism and direct multiorgan failure in COVID-19 patients: Bioinformatic predictions, experimental observations, and open questions |
Anna A. Valyaeva, Anastasia A. Zharikova, Eugene V. Sheval |
| 7 |
[GO] |
2022―Sep―01 |
SARS-CoV-2 vaccines: A double-edged sword throughout rapid evolution of COVID-19 |
Mohammad Ali Zolfaghari, Farzaneh Ghadiri Moghaddam, Shabnam Rajput, Abbas Karimi, Mohadeseh Naghi Vishteh, Ata Mahmoodpoor, et al. (+2) Sanam Dolati, Mehdi Yousefi |
| 8 |
[GO] |
2022―May―06 |
Single nucleotide polymorphisms located in
TNFA, IL1RN, IL6R
, and
IL6
genes are associated with COVID-19 risk and severity in an Iranian population |
Mohsen Rokni, Mohammad Sarhadi, Milad Heidari Nia, Leila Mohamed Khosroshahi, Somaye Asghari, Saman Sargazi, et al. (+2) Shekoufeh Mirinejad, Ramin Saravani |
| 9 |
[GO] |
2022―Mar―24 |
SARS-CoV-2 and Influenza Viruses: Strategies to Cope with Co-infection and Bioinformatics Perspective |
Habib Ghaznavi, Milad Shirvaliloo, Saman Sargazi, Zahra Mohammadghasemipour, Zinat Shams, Zahra Hesari, et al. (+4) Omolbanin Shahraki, Ziba Nazarlou, Roghayeh Sheervalilou, Sakine Shirvalilou |
| 10 |
[GO] |
2021―Aug―10 |
Serological Tests for COVID-19: Potential Opportunities |
Marcarious M. Tantuoyir, Nima Rezaei |
| 11 |
[GO] |
2021―Aug―05 |
Role of Hemagglutinin-esterase protein in SARS-CoV-2 infection? |
Milad Zandi, Saber Soltani |
| 12 |
[GO] |
2021―Jun―28 |
miRNAs; a novel strategy for the treatment of COVID-19 |
Hao Ying, Mohsen Ebrahimi, Mona Keivan, Seyed Esmaeil Khoshnam, Sarvenaz Salahi, Maryam Farzaneh |
| 13 |
[GO] |
2021―May―04 |
COVID-19-related coagulopathy: a review of pathophysiology and pharmaceutical management |
Mahdi Kohansal Vajari, Mahsa Shirin, Atieh Pourbagheri-Sigaroodi, Mohammad Esmaeil Akbari, Hassan Abolghasemi, Davood Bashash |
| 14 |
[GO] |
2021―Apr―05 |
The role of autophagy in controlling of SARS-CoV-2 infection: An overview with virophagy-mediated of molecular drug targets |
Saman Sargazi, Roghayeh Sheervalilou, Mohsen Rokni, Milad Shirvaliloo, Omolbanin Shahraki, Nima Rezaei |
| 15 |
[GO] |
2021―Feb―16 |
Genetic and epigenetic factors associated with increased severity of Covid-19 |
Zafer Yildirim, Oyku Semahat Sahin, Seyhan Yazar, Vildan Bozok Cetintas |
| 16 |
[GO] |
2020―Dec―02 |
Dysregulation of the Immune Response in COVID-19 |
Leila Mohamed Khosroshahi, Nima Rezaei |
| 17 |
[GO] |
2020―Dec―02 |
Serological Tests for COVID-19: Potential Opportunities |
Marcarious M. Tantuoyir, Nima Rezaei |
| 18 |
[GO] |
2020―Sep―29 |
The Possible Double-Edged Sword Effects of Vitamin D on COVID-19: A Hypothesis |
Ehsan Shojaeefar, Narges Malih, Nima Rezaei |
| 19 |
[GO] |
2020―Aug―07 |
Stem Cell Therapy for Covid-19: Possibilities and Challenges |
Mahmood S Choudhery, David T Harris |
| 20 |
[GO] |
2020―May―27 |
Lymphopenia in COVID-19: Therapeutic Opportunities |
Nazanin Fathi, Nima Rezaei |
| 21 |
[GO] |
2020―May―25 |
May we target double membrane vesicles and oxysterol-binding protein to combat SARS-CoV-2 infection? |
Shiva Shahmohamadnejad, Seyed Fazel Nabavi, Solomon Habtemariam, Kasturi Sarkar, Parames C. Sil, Razieh Dowran, Seyed Mohammad Nabavi |
